Nnit A/s · OMXCOP:NNIT
Nnit A/s — Carnegie Small & Mid Cap Seminar 2015
17 slides from Nnit A/s's conference presentation, Sep 3, 2015
Slide 1: NNIT – Carnegie Small & Mid Cap Seminar 2015
NNIT Carnegie Small & Mid Cap Seminar 2015 Stockholm 3 September 2015
Slide 2: Forward looking statements
Forward looking statements This presentation contains forward-looking statements. Words such as ‘believe’, ‘expect’, ‘may’, ‘will’, ‘plan’, ‘strategy’, ‘prospect’, ‘foresee’, ‘estimate’, ‘project’, ‘anticipate’, ‘can’, ‘intend’, ‘outlook’, ‘guidance’, ‘target’ and other words and terms of similar me
Slide 3: Leveraging our Novo Nordisk Heritage and Differentiated Compliance DNA
Leveraging our Novo Nordisk Heritage and Differentiated Compliance DNA to Win Profitable Market Shares Danish IT Market Leader Top 3 Leading market share in IT services market in Denmark and Fastest Growing Player (1) Global Delivery Model Market Share Winner with Historical Organic Revenue Growth 3
Slide 4: Leveraging Our Compliance DNA Drives Diversification
Leveraging Our Compliance DNA Drives Diversification Our Core Leveraging Our Compliance DNA Life Public Finance Enterprise Sciences DKK 1,547m DKK 326m DKK 166m DKK 371m (64%) (14%) (7%) (15%) See Note (1) DKK 743m (31%) IT Solutions Services: Advisory services, business solutions and application ma
Slide 5: We Have a Strong Expertise in Life Sciences…
We Have a Strong Expertise in Life Sciences… NNIT Delivers Value Added Solutions to Well- Recognized …. Thanks to Leading-Edge Solutions Tailored to Life Pharmaceutical Groups by focusing… Sciences Selected pharmaceutical companies Unique, in-depth familiarity with processes, requirements and te
Slide 6: Deep Array of Differentiated Solutions
Deep Array of Differentiated Solutions Integrated Drug Integrated Drug Integrated Quality Integrated Supply Development Regulatory Affairs Management Chain • • • • Strategy Clinical Information Regulatory Compliance Strategic Planning Management Information Assessments • Manufacturing & SC Initiatio
Slide 7: The Key Pillars of Our Growth Strategy
The Key Pillars of Our Growth Strategy 1 Increase our share of existing customers’ IT spending 2 In Denmark Win new customers 2020 Strategy 3 Support Danish customers with their internationalization Win Profitable Market Share 4 Internationally Life Sciences Supporting Pillars 5 Continue our cost
Slide 8: First six month of 2015 at a glance
First six month of 2015 at a glance Constant Reported vs. 6M 2014 vs. 6M 2014 currencies currencies (constant curr.) (reported curr.) Revenue DKK 1,234m DKK 1,244m +8.8% +9.7% Operating profits DKK 132m DKK 114m +20.1% +3.7% Operating profit margin 10.7% 9.2% +1.0pp -0.5pp Net profits DKK 94m +10.1%
Slide 9: Backlog development
Backlog development Backlog for 2015 increased 10.0% y-o-y to DKK 2,340m driven by: • Order backlog intake for delivery in 2015 is DKK 423 million in 6M 2015 • New contracts in public and life sciences segments • Extension and expansion of infrastructure and support agreements with Novo Nordisk • Ex
Slide 10: Continue to gain market shares in Denmark
Continue to gain market shares in Denmark Danish IT Services Market Development vs. NNIT +x% 2013-2014 YoY Growth -8% 6,000 5,289 Danish IT service market 2014 5,000 +2% Growth 2013-2014 was 1.2% 4,033 4,000 Market size: 34.9 bn DKK +10% NNIT market share was 7% (2013: 6%) 3,000 2,320 -5% +13%
Slide 11: Financial statement first six month
Financial statement first six month Pct/pp Pct/pp 6M 2015 6M 2015 DKK million 6M 2014* Change Change (reported) (constant*) (reported) (constant) Revenue 1,244.4 1,234.4 1,134.6 9.7% 8.8% Cost of goods sold 1,012.6 987.1 923.9 9.6% 6.8% Gross profit 231.7 247.3 210.6 10.0% 17.4% Gross profit margin
Slide 12: Segment development
Segment development Revenue Revenue Revenue Pct Change Pct Change DKKm 6M 2015 6M 2015 6M 2014* (reported) (constant) (reported) (constant*) Life Sciences 770.3 760.6 721.0 6.8% 5.5% Hereof Novo Nordisk Group 604.1 597.7 585.0 3.3% 2.2% Hereof other Life Sciences 166.1 162.9 136.0 22.1% 19.7% Public
Slide 13: IT Operations
IT Operations Pct/pp Pct/pp 6M 2015 6M 2015 6M 2014* Change Change (reported) (constant*) (reported) (constant*) DKK million Revenue Novo Nordisk Group 403.0 397.7 401.0 0.5% -0.8% Non-Novo Nordisk Group 420.4 419.6 393.3 6.9% 6.7% Total 823.4 817.4 794.3 3.7% 2.9% Costs 755.7 735.5 703.3 7.4% 4.6%
Slide 14: IT Solutions
IT Solutions * Constant currencies measured using average exchange rates in first 6M of 2014 Revenue growth of 22.6% in constant currencies and 23.7% in reported currency • Partly influenced by 6M 2014 events (reversal of revenue and compensation for a terminated contract) • Growth net of these two
Slide 15: Datacenter
Datacenter Current state • Owned Tier 4 datacenter in Denmark • 1,200m2 and 2,000 kVa • Rented capacity in secondary datacenter Denmark • Operating datacenters in US and China Analysis • Whether to build additional tier 4 datacenter or to lease • Business case and demand driven decision • Security,
Slide 16: Outlook
Outlook Current guidance Previous guidance Revenue 6-8% at constant currencies 5-8% at constant currencies growth Around 0.7pp higher as reported Around 0.8pp higher as reported Operating Around 11% at constant currencies Around 11% at constant currencies margin Around 1.3pp lower as reported Around
Slide 17: Investor contact information
Investor contact information Upcoming events 3 September 2015: Presentation at Carnegie Small & Mid Cap seminar, Stockholm 17 November 2015: Interim report for first nine months of 2015 24 November 2015: Presentation at ABG Sundal IT seminar, Copenhagen 3 December 2015: Presentation at Danske Bank M